Drug
Sea Cd70
Sea Cd70: highest development phase Phase 1, developed by Seagen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Seagen
Trials
| Drug | Phase | Indication |
|---|---|---|
| SEA-CD70 NCT04227847 | Phase 1 | Myelodysplastic Syndrome |
Latest
No recent events.
Follow Sea Cd70 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.